AEHR vs NTES
Aehr Test Systems vs NetEase, Inc. — AI-powered side-by-side comparison
AEHR
Aehr Test Systems
54
Watch
VS
NTES
NetEase, Inc.
68
Buy
| Metric | AEHR | NTES |
|---|
| AI Score |
54
|
68
|
| Price |
$117.30
|
$127.86
|
| P/E Ratio |
-509.48×
|
16.36×
|
| ROE |
-3.2%
|
21.0%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
34.7%
|
65.7%
|
| Debt / Equity |
0.04×
|
0.07×
|
| Dividend Yield |
0.0%
|
2.3%
|
| RSI (14) |
72.5
|
44.6
|
| Beta |
3.087
|
0.8
|
| Expected Upside |
—
|
—
|
AI Committee View
Current Innellis committee reasoning for AEHR versus NTES.
NTES leads by 14 points.
NTES scores 68/100 (Buy) versus AEHR at 54/100 (Watch).
AEHR Committee View
50% agreement
6 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Growth Analyst remains cautious — revenue declining -26.4% yoy -- this is not a growth story right now. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- ROE of only -8.9% -- cheap may mean cheap for a reason — Value
- Revenue declining -26.4% YoY -- this is not a growth story right now — Growth
- RSI at 72 is in overbought territory — Technical
NTES Committee View
83% agreement
6 analysts
The primary driver is news sentiment is positive (+0.67 across 3 articles, 14d). Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- ROE of 21.6% shows genuine earnings power backing the valuation — Value
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical